SEC 13F Intelligence

Octagon Capital Advisors LP / PALI

Octagon Capital Advisors LP’s Palisade Bio Inc Position

Does Octagon Capital Advisors LP own Palisade Bio Inc (PALI)? Yes10.28M shares worth $18M (+1.99% of its 13F portfolio) as of Q1 2026, up from 9.57M shares the prior filed quarter.

Position Value
$18M
Q1 2026
Shares
10.28M
% of Portfolio
+1.99%
Quarters Held
2
currently held

Position History PALI

Reported value by quarter
Q4 ’25: $22MQ4 ’25Q1 ’26: $18MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202610.28M$18M+1.99%
Q4 20259.57M$22M+2.73%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of PALI.